Secukinumab in mode-severe CD
Infliximab switch to adalimumab in CD
Tacrolimus in steroid dependent UC
Infliximab stop in CD
Adalimumab in UC
Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled trial
Adalimumab in CD
Adalimumab in paediatric CD
Infliximab in postoperative recurrence in CD
Mesalazine in UC once or twice daily